Monthly Archives: September 2022

2022-09-18: News Headlines

Marco P. Schott (2022-09-18). The thought matrix expands. indybay.org Who has followed the change of the Internet over the last 10 years carefully, will agree with me that the at the beginning very wide spectrum of knowledge, which was available to one in the www, became thinner and thinner and more and more limited. Censorship and deletion of search results is becoming more and more obvious.

Amy S Paller, Eric L Simpson, Elaine C Siegfried, Michael J Cork, Andreas Wollenberg, Peter D Arkwright, Weily Soong, Mercedes E Gonzalez, Lynda C Schneider, Robert Sidbury, Benjamin Lockshin, Steven Meltzer, Zhixiao Wang, Leda P Mannent, Nikhil Amin, Yiping Sun, Elizabeth Laws, Bolanle Akinlade, Myles Dillon, Matthew P Kosloski, Mohamed A Kamal, Ariane Dubost-Brama, Naimish Patel, David M Weinreich, George D Yancopoulos, John T O'Malley, Ashish Bansal, participating investigators (2022-09-17). [Articles] Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial. thelancet.com Dupilumab significantly improved atopic dermatitis signs and symptoms versus placebo in children younger than 6 years. Dupilumab was well tolerated and showed an acceptable safety profile, similar to results in older children and adults.

Anne-Sofie Halling, Jacob P Thyssen (2022-09-17). [Comment] Biological therapy for young children with atopic dermatitis. thelancet.com Atopic dermatitis is a common inflammatory skin disease that might lead to severe and persistent disease during infancy. Atopic dermatitis is associated with poor school performance, psychiatric disease, and allergic comorbidities.1—3 If atopic dermatitis is inadequately controlled with emollient use and topical anti-inflammatory therapies, systemic medications including ciclosporin, azathioprine, and methotrexate can be used to treat children with moderate-to-severe disease. However, systemic therapies are rarely used in children because the natural disease course often leads to spontaneous improvement, an…

2022-09-18 22:02 | 18:02 EST | tr | 5 | 0 | 2 | 1 | 0 

2022-09-17: News Headlines

Marco P. Schott (2022-09-17). The thought matrix expands. indybay.org Who has followed the change of the Internet over the last 10 years carefully, will agree with me that the at the beginning very wide spectrum of knowledge, which was available to one in the www, became thinner and thinner and more and more limited. Censorship and deletion of search results is becoming more and more obvious.

Anne-Sofie Halling, Jacob P Thyssen (2022-09-17). [Comment] Biological therapy for young children with atopic dermatitis. thelancet.com Atopic dermatitis is a common inflammatory skin disease that might lead to severe and persistent disease during infancy. Atopic dermatitis is associated with poor school performance, psychiatric disease, and allergic comorbidities.1—3 If atopic dermatitis is inadequately controlled with emollient use and topical anti-inflammatory therapies, systemic medications including ciclosporin, azathioprine, and methotrexate can be used to treat children with moderate-to-severe disease. However, systemic therapies are rarely used in children because the natural disease course often leads to spontaneous improvement, an…

Amy S Paller, Eric L Simpson, Elaine C Siegfried, Michael J Cork, Andreas Wollenberg, Peter D Arkwright, Weily Soong, Mercedes E Gonzalez, Lynda C Schneider, Robert Sidbury, Benjamin Lockshin, Steven Meltzer, Zhixiao Wang, Leda P Mannent, Nikhil Amin, Yiping Sun, Elizabeth Laws, Bolanle Akinlade, Myles Dillon, Matthew P Kosloski, Mohamed A Kamal, Ariane Dubost-Brama, Naimish Patel, David M Weinreich, George D Yancopoulos, John T O'Malley, Ashish Bansal, participating investigators (2022-09-17). [Articles] Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial. thelancet.com Dupilumab significantly improved atopic dermatitis signs and symptoms versus placebo in children younger than 6 years. Dupilumab was well tolerated and showed an acceptable safety profile, similar to results in older children and adults.

_____ (2022-09-16). Ukraine — Dissecting Some War Propaganda News Items. popularresistance.org Last night a Reuters headline claimed: Mass grave of more than 440 bodies found in Izium, Ukraine -policeÔªø. | The Reuters headline was 100% false. That may have been because the editor misinterpreted what the Ukrainian police investigator said. Or it intentionally exaggerated the case to increase the propaganda value of that news item. I suspect the latter to be the case. | There is otherwise nothing unusual with that graveyard. During a war people on both sides die. Civilians suffer as much as soldiers while fighting around them is going on. The city had been heavily defended by the Ukrainian…

Kevin Gosztola (2022-09-16). Censorship Is A Bedrock of Incarceration In The United States. thedissenter.org Brian Nam-Sonenstein, co-host of "Beyond Prisons," appears on "Unauthorized Disclosure," to outline the issue of censorship in US prisons.

Luca GoldMansour (2022-09-16). Corporate Media Is Trying to Convince People Student Debt Forgiveness Is Bad. commondreams.org By trying to convince voters that debt relief will cost them, and that a more egalitarian society is impossible, corporate media are defending America's ruling class from an educated working class.

2022-09-17 21:07 | 17:07 EST | tr | 8 | 0 | 3 | 3 | 0